Psychedelic Medicine

Researchers are reporting positive results from an early trial exploring the safety profile of psilocybin doses in healthy adults. The trial also explored the potential of group dosing sessions as a way to speed up research and expand patient access.

Predicting a wave of psychedelic legalization over the coming decade, start-up Silo Wellness has developed a magic mushroom nasal spray focused on delivering controlled psychedelic microdoses. New Atlas spoke to CEO Mike Arnold to learn more.

An incredible new study has found a specifically timed infusion of ketamine can rewrite maladaptive reward memories. Subjects with harmful alcohol behaviors significantly reduced their drinking for nine months following a single ketamine treatment.

New research is presenting evidence that cannabis can significantly reduce the severity of headaches and migraines. But the question remains: why are scientists coming up with such discordant results on whether cannabis can reduce pain?

The US Food and Drug Administration (FDA) has granted psilocybin therapy a Breakthrough Therapy designation for the second time in a year, this time with a view on accelerating trials testing its efficacy treating major depressive disorder (MDD).

An intriguing new study from Imperial College London is shedding light on how one of the world’s most powerful psychedelic substances alters brain activity, rapidly shifting a person’s brainwaves into a state that resembles dreaming.

A new study has for the first time revealed one of the molecular mechanisms by which CBD directly blocks the negative psychiatric side effects generated by THC.

Can a drug-induced psychedelic experience be replicated by virtual reality? Or, can VR induce its own unique altered state of consciousness?

A new research program from DARPA is looking to remove those pesky hallucinatory side effects from psychedelic medicines such as MDMA & psilocybin.

In a first for the US, Johns Hopkins University is launching a research center dedicated to investigating psychedelic compounds.

Scientists at Johns Hopkins University are beginning a world-first human clinical trial on the effects of psilocybin therapy in persons with anorexia.

CBD is now an FDA-approved medicine, but there has been very little study into how food affects the cannabis-derived compound’s absorption. A valuable new study has strikingly found that CBD absorption is significantly increased when it is consumed alongside high-fat foods.